Last update 27 Jan 2026

CS-20AT04

Overview

Basic Info

Drug Type
Mesenchymal stem cell therapy
Synonyms
CS 20 AT 04, CS 20AT04, CS20AT04-LN101
+ [1]
Target-
Action-
Mechanism
Cell replacements
Therapeutic Areas
Immune System DiseasesSkin and Musculoskeletal DiseasesUrogenital Diseases
Active Indication-
Inactive Indication
Autoimmune cytopeniasLupus Nephritis
Originator Organization
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
Active Organization-
Inactive Organization
Hanyang UniversityHanyang UniversityCORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

3
Clinical Trials associated with CS-20AT04
NCT04835883
/ Unknown statusPhase 2IIT
Open-label, Single-arm, 24-week Investigator Study to Evaluate the Efficacy and Safety of CS20AT04 (HLA-haplo Matched Allogenic Bone Marrow-Derived Stem Cells) Administered in Patients With Lupus Nephritis or Lupus Cytopenia
NCT04522505
/ CompletedNot Applicable
Long-term Follow-up for Safety Evaluation of Subjects Who Participated in the Phase 1 Clinical Trial of CS20AT04(CS20AT04-LN101) in Lupus Nephritis
NCT03174587
/ CompletedPhase 1
A Phase 1 Study to Evaluate the Safety of CS20AT04 Inj. in Subjects With Lupus Nephritis.
100 Clinical Results associated with CS-20AT04
Login to view more data
100 Translational Medicine associated with CS-20AT04
Login to view more data
100 Patents (Medical) associated with CS-20AT04
Login to view more data
100 Deals associated with CS-20AT04
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Autoimmune cytopeniasPhase 2
South Korea
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
26 Sep 2019
Lupus NephritisPhase 2
South Korea
CORESTEMCHEMON, Inc.CORESTEMCHEMON, Inc.
26 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free